Article in Molecules (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
12 authors.
Alena S KarandeevaInstitute of Chemistry and Chemical Technology, Yaroslavl State Technical University, Moskovskii Prosp. 88, 150023 Yaroslavl, Russia.ORCID 0009-0005-4464-0047
Natalia A BogdanovaInstitute of Chemistry and Chemical Technology, Yaroslavl State Technical University, Moskovskii Prosp. 88, 150023 Yaroslavl, Russia.ORCID 0009-0006-3760-6307
Mariya V KabanovaInstitute of Chemistry and Chemical Technology, Yaroslavl State Technical University, Moskovskii Prosp. 88, 150023 Yaroslavl, Russia.
Sergey I FilimonovInstitute of Chemistry and Chemical Technology, Yaroslavl State Technical University, Moskovskii Prosp. 88, 150023 Yaroslavl, Russia.
Zhanna V ChirkovaInstitute of Chemistry and Chemical Technology, Yaroslavl State Technical University, Moskovskii Prosp. 88, 150023 Yaroslavl, Russia.
Anna A RomanychevaPharmaceutical Technology Transfer Centre, Yaroslavl State Pedagogical University Named After K.D. Ushinsky, Respublikanskaya Str. 108, 150000 Yaroslavl, Russia.ORCID 0000-0002-7931-1711
Valeria A PanovaPharmaceutical Technology Transfer Centre, Yaroslavl State Pedagogical University Named After K.D. Ushinsky, Respublikanskaya Str. 108, 150000 Yaroslavl, Russia.
Anton A ShetnevPharmaceutical Technology Transfer Centre, Yaroslavl State Pedagogical University Named After K.D. Ushinsky, Respublikanskaya Str. 108, 150000 Yaroslavl, Russia.ORCID 0000-0002-4389-461X
Nurila A TogyzbayevaLaboratory of Engineering Profile, Korkyt Ata Kyzylorda University, Aiteke Bi Str., 29A, 120014 Kyzylorda, Kazakhstan.ORCID 0000-0003-4310-0661
Saken A KanzharLaboratory of Engineering Profile, Korkyt Ata Kyzylorda University, Aiteke Bi Str., 29A, 120014 Kyzylorda, Kazakhstan.ORCID 0000-0003-4553-3049
Nurbol O AppazovLaboratory of Engineering Profile, Korkyt Ata Kyzylorda University, Aiteke Bi Str., 29A, 120014 Kyzylorda, Kazakhstan.
Kyrill Yu SuponitskyA. N. Nesmeyanov Institute of Organoelement Compounds, Russian Academy of Sciences, Build. 1, Vavilova Str. 28, 119991 Moscow, Russia.ORCID 0000-0003-0617-0118
Funding
Russian Science Foundation 25-23-00728
6 · The paper itself
Abstract
This study reports an improved diastereoselective synthesis of substituted spiro[chromane-2,4'-pyrimidin]-2'(3'
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Diastereoselective Synthesis and Biological Evaluation of Spiro[chromane-2,4'-pyrimidin]-2'(3' · full record | OpenQuestion